C3 PROACTIVATOR CONVERTASE(FACTOR-D)

被引：0
|
作者：
LESAVRE, P [1 ]
MULLEREBERHARD, HJ [1 ]
机构：
[1] SCRIPPS CLIN & RES FDN,RES INST,LA JOLLA,CA 92037
来源：
FEDERATION PROCEEDINGS | 1978年 / 37卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：1378 / 1378
页数：1
相关论文
共 50 条
  • [41] Stability of C3 convertase in the rat classical complement pathway
    Naito, A
    Okada, H
    MICROBIOLOGY AND IMMUNOLOGY, 1997, 41 (08) : 621 - 624
  • [42] IN VITRO MODELING OF THE GLYCOMATRIX TO STUDY KINETICS OF C3 CONVERTASE
    Pisarenka, Sofiya
    Xiao, Xue
    Zhang, Yuzhou
    Smith, Richard
    MOLECULAR IMMUNOLOGY, 2019, 114 : 435 - 435
  • [43] Decay acceleration of the complement alternative pathway C3 convertase
    Hourcade, DE
    Mitchell, LM
    Medof, ME
    IMMUNOPHARMACOLOGY, 1999, 42 (1-3): : 167 - 173
  • [44] SYNTHESIS OF FACTOR-D, FACTOR-B AND FACTOR-P OF ALTERNATIVE PATHWAY OF COMPLEMENT ACTIVATION, AS WELL AS OF C3, BY GUINEA-PIG PERITONEAL MACROPHAGES INVITRO
    BENTLEY, C
    FRIES, W
    BRADE, V
    IMMUNOLOGY, 1978, 35 (06) : 971 - 980
  • [45] Crystal structure of the C3 convertase complex inhibited by SCIN
    Wu, Jin
    Janssen, Bert
    Rooijakkers, Suzan
    Ruyken, Maartje
    Gomes, Lucio
    van Strijp, Jos
    Gros, Piet
    MOLECULAR IMMUNOLOGY, 2008, 45 (16) : 4119 - 4119
  • [46] Treating Dense Deposit Disease by controlling the C3 convertase
    Zhang
    Marsh, H.
    Sethi, S.
    Smith, R. J. H.
    MOLECULAR IMMUNOLOGY, 2011, 48 (14) : 1715 - 1715
  • [47] Identification of intermolecular bonds between human factor B and Cobra Venom Factor important for C3 convertase stability
    Hew, Brian E.
    Pangburn, Michael K.
    Vogel, Carl-Wilhelm
    Fritzinger, David C.
    TOXICON, 2020, 184 : 68 - 77
  • [48] DEVELOPMENTAL ASPECTS OF COMPLEMENT COMPONENTS IN NEWBORN - PRESENCE OF COMPLEMENT COMPONENTS AND C3 PROACTIVATOR (PROPERDIN FACTOR B) IN HUMAN COLOSTRUM
    BALLOW, M
    FANG, F
    GOOD, RA
    DAY, NK
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1974, 18 (02): : 257 - 266
  • [49] GINGIVAL FLUID AND SERUM IN PERIODONTAL-DISEASES .2. EVIDENCE FOR CLEAVAGE OF COMPLEMENT COMPONENTS C3, C3 PROACTIVATOR (FACTOR-B) AND C4 IN GINGIVAL FLUID
    SCHENKEIN, HA
    GENCO, RJ
    JOURNAL OF PERIODONTOLOGY, 1977, 48 (12) : 778 - 784
  • [50] C3 REQUIREMENTS FOR FORMATION OF ALTERNATIVE PATHWAY C5 CONVERTASE
    DAHA, MR
    FEARON, DT
    AUSTEN, KF
    JOURNAL OF IMMUNOLOGY, 1976, 117 (02): : 630 - 634
12345